Painkillers
Small molecule
Painkillers is one of 26 small molecule programs targeting Rib Fracture. It is currently in development.
1
Indications
2
Total Trials
0
Active Trials
25
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
45 competitors in Rib Fracture
#DrugCompanyPhaseTrials
1Journavx
Vertex PharmaceuticalsApproved
Xylocaine
MMEDRx USA, Inc.
Approved
Naropin
FFresenius Kabi Oncology Ltd.
Approved
Tylenol
KKenvue Brands
Approved
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Approved
Marcaine
IInnocoll
Approved
Ketalar
AAultman Health Foundation
Approved
Protonix
WWyeth-Lederle Vaccines
Approved
Advil
KKenvue Brands
Approved
Opioid
Johnson & JohnsonApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Painkillers. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Company
- UUniversity of Valencia